Skip to main content

Press

Call for Applications

ISPNO/SNO Pediatric Low-Grade Glioma Research Fellowship

The International Symposium on Pediatric Neuro-Oncology (ISPNO) and the Society for Neuro-Oncology (SNO) are pleased to announce the establishment of a new annual Pediatric Low-Grade Glioma Research Fellowship! This fellowship aims to support postdoctoral, clinical, fellow, or junior faculty members in conducting research focused on pediatric low-grade glioma (pLGG) outcomes.

Apply for Fellowship!

Deadline: Tuesday, October 1, 2024

Please carefully review the information below before submitting your application.

  • Purpose

    The fellowship seeks to encourage and facilitate the development of successful career paths in the field of Pediatric Neuro-Oncology by supporting innovative research projects directly applicable to pLGG. This fellowship will also consider proposals investigating the long-term effects of targeted therapies in pediatric brain tumors.

  • Funding

    Thanks to the generous support of Day One Biopharmaceuticals, the fellowship will provide one grant of $75,000 in each calendar year, inclusive of indirect costs. The funding is specifically designated for the Pediatric Low-Grade Glioma Research Fellowship.

  • Application Process

    Interested candidates are invited to submit their research proposals according to the guidelines outlined in the grant application form. Proposals should address the significance of the research, proposed methodologies, expected outcomes, and relevance to pLGG.

  • Deadline

    The deadline for submitting applications is Tuesday, October 1, 2024. Late submissions will not be considered.

  • Administration

    The Society for Neuro-Oncology (SNO) will administer the fellowship. SNO will oversee the submission and review process and distribute funds to the selected awardee.

  • Award Process

    An impartial joint awards committee, comprising representatives from ISPNO and SNO leadership, will evaluate fellowship applications based on the merit of the proposed research and select the award recipient(s) after a rigorous review process.

  • How to Apply

    To apply for the ISPNO/SNO Pediatric Low-Grade Glioma Research Fellowship, please click here and complete the online application form. In addition to the application questions, applicants will be required to upload a biographical sketch, a reference from their department chair or a mentor describing their involvement in the research, a budget outlining how the funds will be used, and any other supporting documents requested by the funders. 

  • Contact Information

    For inquiries regarding the fellowship or the application process, please contact Shelley Pressley at [email protected]. 

    We encourage qualified candidates with a passion for pediatric neuro-oncology research to apply for this prestigious fellowship opportunity. Together, we can advance our understanding of pLGG and improve outcomes for pediatric patients worldwide.

  • Terms and Conditions

    By submitting an application for the ISPNO/SNO Pediatric Low-Grade Glioma Research Fellowship, applicants agree to comply with the terms and conditions provided here.

About the Partners



Founded in 1995, the Society for Neuro-Oncology is a multidisciplinary organization of medical professionals dedicated to promoting advances in neuro-oncology (brain tumors) through research and education. The Society publishes three journals on the subject of neuro-oncology, and organizes conferences throughout the year on various topics relevant to its membership. Held each year in November, the SNO Annual Meeting is considered to be the leading nexus for scientists and clinician-researchers to share the latest findings from the field. SNO has an active membership of over 3000 physicians and allied health professionals. 


The International Symposium of Pediatric Neuro-Oncology (ISPNO) is a global conference dedicated to advancing the field of pediatric neuro-oncology. Held biennially, ISPNO brings together leading researchers, clinicians, and healthcare professionals from around the world to discuss the latest developments in the diagnosis, treatment, and management of brain and spinal cord tumors in children. (ISPNO 2024) will be held in Philadelphia, PA, from June 29 – July 2, 2024. 


Day One Biopharmaceuticals is a commercial-stage biopharmaceutical company that believes when it comes to pediatric cancer, we can do better. The Company was founded to address a critical unmet need: the dire lack of therapeutic development in pediatric cancer. Inspired by “The Day One Talk” that physicians have with patients and their families about an initial cancer diagnosis and treatment plan, Day One aims to re-envision cancer drug development and redefine what’s possible for all people living with cancer—regardless of age—starting from Day One.